Red Light Therapy for Menstrual Cramps: Evidence, Mechanism and Best Devices
TL;DR
- Red light therapy has a growing and genuinely compelling evidence base for menstrual cramps, with a 2025 systematic review and meta-analysis of 12 randomised controlled trials involving 645 participants finding that light therapy significantly reduced menstrual pain compared to placebo.
- In a landmark multicentre trial, red light therapy at 630nm performed comparably to oral contraceptive pills for pain reduction and prostaglandin E2 regulation over three consecutive menstrual cycles, with no side effects.
- The mechanism is directly relevant to the biology of menstrual pain: photobiomodulation reduces prostaglandin E2 production through COX-2 inhibition, modulates uterine smooth muscle tension, improves pelvic circulation, and activates endogenous pain-modulating pathways.
- Wearable devices applied directly to the lower abdomen are the most practical format for menstrual cramp applications, delivering therapeutic irradiance to the uterine area without requiring the user to remain stationary during sessions.
- Both preventative use in the days before menstruation and acute use during cramping are supported by the research. Pre-menstrual sessions help reduce the inflammatory load before it peaks. Acute sessions address active cramping directly.
Menstrual cramps, or primary dysmenorrhea, affect an estimated 45 to 95% of women of reproductive age and represent one of the leading causes of work and school absenteeism in young women globally. For many, the standard options of NSAIDs and oral contraceptive pills are effective but come with side effects, contraindications, or simply the desire for a non-pharmacological alternative.
Red light therapy has emerged as one of the more scientifically credible non-drug options for managing period pain, with a body of research that has grown significantly in the past few years and now includes a 2025 meta-analysis directly comparing it to oral contraceptives. This article covers what the research actually shows, the mechanism behind how it works, and how to use it effectively at home.
What Causes Menstrual Cramps
Primary dysmenorrhea, the term for painful periods without an underlying condition like endometriosis, is driven primarily by excessive production of prostaglandins, particularly prostaglandin E2 (PGE2) and prostaglandin F2-alpha (PGF2α), in the uterine lining during menstruation. These prostaglandins cause powerful uterine muscle contractions, vasoconstriction of the blood vessels supplying the uterus, and sensitisation of pain receptors in the uterine tissue.
The result is the familiar cramping pain in the lower abdomen and pelvis, often radiating to the lower back and upper thighs, that characterises dysmenorrhea. Prostaglandin levels peak in the first one to two days of menstruation, which is why pain is typically worst at the onset of bleeding.
NSAIDs work by inhibiting COX enzymes that synthesise prostaglandins. The oral contraceptive pill works by suppressing ovulation and thinning the uterine lining, which reduces prostaglandin production. Understanding this mechanism is important because red light therapy addresses the same prostaglandin pathway through a different biological route.
How Red Light Therapy Works for Menstrual Cramps
Prostaglandin Reduction Through COX-2 Inhibition
Red light therapy inhibits COX-2, the enzyme responsible for prostaglandin synthesis, through a photochemical mechanism: by reducing reactive oxygen species in cells, photobiomodulation suppresses COX-2 activity and consequently reduces PGE2 production. The multicentre trial comparing LLLT to oral contraceptives specifically measured serum prostaglandin E2 levels and found that both treatments produced significant reductions, confirming that red light therapy's analgesic effect in dysmenorrhea is mechanistically grounded in prostaglandin modulation rather than purely subjective pain perception changes.
Uterine Smooth Muscle Relaxation
Near-infrared light penetrates into the lower abdominal and pelvic region, reaching uterine smooth muscle tissue where it increases ATP production through mitochondrial activation. Improved cellular energy availability in uterine smooth muscle supports more controlled contractile function and reduces the excessive, painful spasms that characterise dysmenorrhea. Nitric oxide released through cytochrome c oxidase activation also contributes to smooth muscle relaxation through its vasodilatory effects on the blood vessels supplying the uterus.
Improved Pelvic Circulation
Prostaglandin-driven vasoconstriction reduces blood flow to the uterus during menstruation, contributing to ischaemic pain similar to the mechanism of angina in cardiac tissue. Red light therapy's nitric oxide-mediated vasodilation improves pelvic circulation, counteracting this vasoconstriction and improving oxygen delivery to the uterine muscle. Improved circulation also accelerates the clearance of pain-producing metabolites from the uterine tissue.
Endogenous Pain Modulation
Photobiomodulation activates descending pain-modulating pathways and supports endorphin release, contributing to the analgesic effects documented in clinical trials. This central pain modulation mechanism complements the peripheral prostaglandin and circulation mechanisms, which is why the pain relief from red light therapy tends to be both local and general in character.
What the Research Shows
The 2025 Systematic Review and Meta-Analysis
A 2025 systematic review and meta-analysis published in a peer-reviewed journal pooled data from 12 randomised controlled trials involving 645 participants with primary dysmenorrhea. The review found that light therapy significantly reduced menstrual pain compared to placebo treatments across multiple validated pain scales. In several comparisons, LLLT performed similarly to or better than oral contraceptives for pain reduction, with virtually no adverse events reported across the treatment groups. This is the most comprehensive summary of the dysmenorrhea photobiomodulation literature and establishes a strong evidence base for its clinical use.
LLLT vs Oral Contraceptive Pills: The Landmark Comparison
A prospective randomised multicentre trial comparing red light therapy at 630nm to oral contraceptive pills (ethinyl estradiol and desogestrel) over three consecutive menstrual cycles enrolled 156 patients. Both groups achieved significant pain reduction on the VAS, and both groups showed significant reductions in serum prostaglandin E2 levels. The LLLT group achieved comparable outcomes to the OCP group with no hormonal side effects, no requirement for daily pill adherence, and no effect on the menstrual cycle itself. For women who want effective pain management without hormonal intervention, this trial is the most directly relevant piece of evidence available.
The 2024 Pulsed 630nm Crossover Trial
A 2024 prospective randomised crossover trial examining pulsed 630nm LED therapy applied to the lower abdomen in women with primary dysmenorrhea found significant relief of menstrual pain compared to white light placebo and improved quality of life scores. The crossover design, where each participant served as their own control, strengthens the evidence by controlling for individual variation in pain sensitivity. The finding that pulsed delivery at 630nm is effective supports the use of devices with pulse mode settings for menstrual cramp applications specifically.
Double-Blind Korean RCT Over Three Menstrual Cycles
A multicenter double-blind randomised controlled trial conducted across two university hospitals in South Korea enrolled 88 women aged 18 to 35 with primary dysmenorrhea and followed them over three menstrual cycles. The treatment group received self-adhesive low-level light therapy while the control group received an identical sham device. Pain severity was assessed at each cycle using the VAS. The treated group showed consistent and progressive pain reduction over the three cycle follow-up, demonstrating that the benefits accumulate with ongoing treatment rather than being limited to the treatment period alone.
Primary vs Secondary Dysmenorrhea
The research base described above is specifically for primary dysmenorrhea, painful periods without an underlying condition. Secondary dysmenorrhea is period pain caused by a diagnosable condition such as endometriosis, fibroids, adenomyosis, or PCOS.
For secondary dysmenorrhea, red light therapy may provide meaningful symptom relief through the same anti-inflammatory and circulation mechanisms, and the endometriosis-specific research supports its use for that condition in particular. However, secondary dysmenorrhea requires medical diagnosis and management of the underlying condition. Red light therapy is a complementary tool that may reduce pain and improve quality of life, but it does not address the structural causes of secondary dysmenorrhea and should be used alongside appropriate medical care.
If your period pain is severe, has worsened over time, occurs outside of menstruation, or is accompanied by other symptoms, consult your GP or gynaecologist before relying on red light therapy as the primary management approach.
How to Use Red Light Therapy for Menstrual Cramps
Preventative Protocol: Days Before Menstruation
Beginning sessions in the five to ten days before your expected period start date allows the anti-inflammatory and prostaglandin-reducing effects to build before peak prostaglandin production begins. Daily sessions of 15 to 20 minutes over the lower abdomen in the pre-menstrual phase can reduce the intensity of cramping when bleeding begins. This preventative approach is supported by the multi-cycle trial data showing progressive improvement with ongoing treatment.
Acute Protocol: During Active Cramping
During active cramping, sessions of 15 to 20 minutes applied directly over the lower abdomen and pelvic region provide acute relief through the smooth muscle relaxation, circulation improvement, and pain modulation mechanisms. Multiple sessions per day during the worst cramping days are appropriate. The 2024 pulsed 630nm trial documented significant acute pain relief from single sessions, supporting the use of red light therapy as an on-demand tool during active menstruation.
Wavelength and Pulse Settings
Red at 630 to 660nm is the primary wavelength across the dysmenorrhea clinical literature and is the most directly documented for prostaglandin reduction. Near-infrared at 850nm adds deeper tissue penetration to reach uterine smooth muscle more effectively. The 2024 crossover trial specifically found pulsed delivery more effective than continuous light for dysmenorrhea, making devices with 10Hz pulse mode the most evidence-aligned option for acute cramping sessions.
StreamShop Devices for Menstrual Cramps
Portable Red Light Therapy Pad With Near-Infrared
StreamShop's portable red light therapy pad with near-infrared delivers 660nm and 850nm in a flexible wearable format that straps directly over the lower abdomen for hands-free treatment during rest, work, or relaxation. The flexible design conforms to the abdominal contour, maintaining consistent skin contact throughout the session without requiring the user to hold or reposition anything. The 10Hz pulse mode aligns with the strongest evidence for pulsed light in dysmenorrhea applications, and 40Hz mode is included alongside continuous operation. For daily use during both the pre-menstrual preventative phase and acute cramping sessions, the portable pad is the most practical and accessible option in the range.
SS300 Pro Class IIa Medical Grade Panel
StreamShop's SS300 Pro class IIa medical grade panel delivers 175.1 mW/cm² at 15cm across nine wavelengths including 630nm, 660nm, 810nm, 830nm, 850nm, and 940nm through a 30-degree focusing lens. For people wanting a panel device that covers the full lower abdomen and pelvic region at the highest available irradiance, the SS300 Pro provides comprehensive coverage at 92cm in a single panel position. Per-wavelength dimming from 1 to 100% allows the 630nm and 660nm channels to be prioritised for dysmenorrhea sessions, and pulse frequency from 1 to 10,000 Hz includes 10Hz for pain management protocols. As a class IIa medical grade ARTG-listed device, it meets the highest regulatory standard for at-home therapeutic devices in Australia.
Red Light Therapy Laser Mat With 1064nm
StreamShop's red light therapy laser mat with 1064nm combines LED and VCSEL laser technology across six wavelengths including 630nm, 660nm, 830nm, 850nm, 940nm, and 1064nm at 110 mW/cm² over a 1.8m x 80cm surface. Lying on the mat positions the lower back, sacrum, and posterior pelvis in direct contact with the 1064nm VCSEL laser technology, while a panel or pad positioned over the abdomen simultaneously treats the anterior pelvic region. For women wanting comprehensive pelvic coverage including both the uterine and lower back aspects of menstrual pain in a single session, the laser mat addresses the posterior component while a wearable pad or panel covers the anterior. The systemic anti-inflammatory effects of full-body laser mat sessions also address the broader inflammatory burden that contributes to dysmenorrhea severity.
Frequently Asked Questions
Does Red Light Therapy Help With Period Pain?
Yes. A 2025 systematic review and meta-analysis of 12 randomised controlled trials involving 645 participants found that light therapy significantly reduced menstrual pain compared to placebo. A landmark multicentre trial found LLLT at 630nm comparable to oral contraceptive pills for pain reduction and prostaglandin E2 reduction over three menstrual cycles with no side effects. The evidence base for red light therapy for primary dysmenorrhea is now substantial and growing.
How Does Red Light Therapy Reduce Menstrual Cramps?
Through four documented mechanisms: COX-2 inhibition that reduces prostaglandin E2 production (the same pathway NSAIDs target), uterine smooth muscle relaxation through nitric oxide release and improved cellular energy, improved pelvic circulation that counteracts prostaglandin-driven vasoconstriction, and activation of endogenous pain-modulating pathways. The prostaglandin reduction has been confirmed by blood tests in clinical trials, not just subjective pain reporting.
Is Red Light Therapy as Effective as NSAIDs for Period Pain?
The research does not directly compare red light therapy to NSAIDs for dysmenorrhea, but it does compare it to oral contraceptive pills with comparable outcomes. NSAIDs remain a well-established first-line treatment. Red light therapy is most valuable as a complementary approach, a standalone option for people who cannot tolerate or prefer to avoid NSAIDs, or as a preventative tool to reduce overall cramping severity.
When Should I Start Using Red Light Therapy for Period Pain?
For preventative benefit, begin daily sessions five to ten days before your expected period start date. This allows the anti-inflammatory effects to build before peak prostaglandin production begins. During your period, use sessions acutely as needed during active cramping. The multi-cycle trial data suggests progressive improvement with ongoing monthly use rather than relying solely on single-cycle acute sessions.
How Long Should Sessions Be for Menstrual Cramps?
Sessions of 15 to 20 minutes over the lower abdomen are consistent with the clinical trial protocols. Multiple sessions per day during the most severe cramping days are appropriate and safe. For preventative pre-menstrual use, one daily session of 15 to 20 minutes is sufficient.
Can Red Light Therapy Help With Period Pain From Endometriosis or PCOS?
Red light therapy may provide meaningful symptom relief for secondary dysmenorrhea from endometriosis or PCOS through the same anti-inflammatory and circulation mechanisms. Endometriosis-specific research supports its use for pelvic inflammation and pain. However, these conditions require medical diagnosis and management of the underlying cause. Red light therapy should complement rather than replace appropriate medical care for these conditions.
Is Red Light Therapy Safe to Use During Menstruation?
Yes. Red and near-infrared light is non-ionising and does not cause tissue damage at therapeutic doses. There are no contraindications to using it during menstruation. Multiple clinical trials have documented its use specifically during the menstrual cycle with no adverse events reported in treatment groups.